Company
株式会社ONODERA GT Pharma
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We are developing innovative gene therapies that lead the world with an innovative approach that uses the highly safe adeno-associated virus (AAV) as a vector to carry therapeutic genes. The focus is on intractable diseases such as Parkinson's disease, amyotrophic lateral sclerosis (ALS) and Alzheimer's disease.
Loading relationship preview